Recent study by Wang et al. showed that cell division cycle 7-related protein kinase (CDC7) inhibitor XL413 specifically induced the senescence of HCC cells with p53 gene mutation, but exhibited no effect of senescent induction on normal cells, and therefore it could specifically eliminate HCC cells (73). This evidence concerns the gene TP53 and hepatocellular carcinoma.